Capricor Therapeutics, Inc. (FRA:4LN2)
Germany flag Germany · Delayed Price · Currency is EUR
22.05
-2.60 (-10.55%)
At close: Dec 4, 2025

Capricor Therapeutics Revenue

Capricor Therapeutics had revenue of $11.13M USD in the twelve months ending September 30, 2025, down -52.08% year-over-year. In the year 2024, Capricor Therapeutics had annual revenue of $22.27M, down -11.55%.

Revenue (ttm)
$11.13M
Revenue Growth
-52.08%
P/S Ratio
111.40
Revenue / Employee
$69.57K
Employees
160
Market Cap
1.06B EUR

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202422.27M-2.91M-11.55%
Dec 31, 202325.18M22.63M886.81%
Dec 31, 20222.55M2.31M941.85%
Dec 31, 2021244.90K-65.35K-21.06%
Dec 31, 2020310.25K-694.78K-69.13%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition